SEC Form 4 · accession 0001209191-15-084522
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miguel Madero
Director
Period of report
Dec 8, 2015
Accepted (ET)
Dec 10, 2015 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 8, 2015 | M | 6,000 | $5.95 | A | 18,000 | D | |
| Common Stock | Dec 8, 2015 | M | 12,000 | $2.35 | A | 30,000 | D | |
| Common Stock | Dec 8, 2015 | M | 12,000 | $3.60 | A | 42,000 | D | |
| Common Stock | Dec 8, 2015 | M | 12,000 | $18.00 | A | 54,000 | D | |
| Common Stock | Dec 8, 2015 | M | 12,000 | $3.50 | A | 66,000 | D | |
| Common Stock | Dec 8, 2015 | M | 12,000 | $9.775 | A | 78,000 | D | |
| Common Stock | Dec 8, 2015 | M | 6,000 | $18.34 | A | 84,000 | D | |
| Common Stock | Dec 8, 2015 | M | 12,000 | $2.90 | A | 96,000 | D | |
| Common StockF1,F2 | Dec 8, 2015 | S | 40,386 | $30.49 | D | 55,614 | D | |
| Common StockF3 | holding | — | — | — | 369,632 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $5.95 | Dec 8, 2015 | M | 6,000 | D | — | Jun 27, 2022 | Common Stock | 6,000 | 0 | D |
| Stock Option (Right to Buy)F4 | $2.35 | Dec 8, 2015 | M | 12,000 | D | — | Mar 12, 2018 | Common Stock | 12,000 | 0 | D |
| Stock Option (Right to Buy)F4 | $3.60 | Dec 8, 2015 | M | 12,000 | D | — | Mar 11, 2019 | Common Stock | 12,000 | 0 | D |
| Stock Option (Right to Buy)F4 | $18.00 | Dec 8, 2015 | M | 12,000 | D | — | Nov 13, 2014 | Common Stock | 12,000 | 0 | D |
| Stock Option (Right to Buy)F4 | $3.50 | Dec 8, 2015 | M | 12,000 | D | — | Mar 15, 2021 | Common Stock | 12,000 | 0 | D |
| Stock Option (Right to Buy)F4 | $9.775 | Dec 8, 2015 | M | 12,000 | D | — | Apr 17, 2023 | Common Stock | 12,000 | 0 | D |
| Stock Option (Right to Buy)F5 | $18.34 | Dec 8, 2015 | M | 6,000 | D | — | Jun 3, 2025 | Common Stock | 6,000 | 6,000 | D |
| Stock Option (Right to Buy)F4 | $2.90 | Dec 8, 2015 | M | 12,000 | D | — | Jun 9, 2020 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1The shares were sold by the reporting person to cover the exercise price and the taxes realized upon the exercise of such options.
- F2The shares were sold at prices ranging from $30.35 to $30.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares are held in accounts for the benefit of family members of the reporting person. The reporting person maintains voting and dispositive power over the shares held in such accounts.
- F4Fully vested.
- F5The shares subject to the option vest and become exercisable quarterly over one year measured from June 3, 2015.